Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases

American Journal of Surgical Pathology

Volumn 24, Issue 2, 2000, Pages 197-202

  Tsuda, Hitoshi ^a   Takarabe, Teruko ^a   Hasegawa, Fumio ^a   Fukutomi, Takashi ^b   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Brain metastasis; Breast cancer; Large, central acellular zone; Lung metastasis; Myoepithelial differentiation

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRAIN METASTASIS; BREAST BIOPSY; BREAST CARCINOMA; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LUNG METASTASIS; MAJOR CLINICAL STUDY; MYOEPITHELIUM; PREDICTION; PROGNOSIS; RISK ASSESSMENT;

ACTINS; ADULT; AGED; BRAIN NEOPLASMS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL DIFFERENTIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KERATINS; LUNG NEOPLASMS; MIDDLE AGED; MYOEPITHELIOMA; PROGNOSIS; S100 PROTEINS; SURVIVAL RATE;

EID: 0033952627     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200002000-00005     Document Type: Article

References (10)

1. Cox DR. Regression models and life tables. J R Stat Soc Br 1972; 34:187-220.
2. Haimoto H, Hosoda S, Kato K. Differential distribution of immunoreactive S-100-α and S-100-β proteins in normal non-nervous human tissues. Lab Invest 1987;57:489-98.
3. Iwaya K, Tsuda H, Fukutomi T, Suzuki M, Hirohashi S. Histologic grade and p53 immunoreaction as indicators of early recurrence of node-negative breast cancer. Jpn J Clin Oncol 1997;27:6-12.
4. Kamby C, Anderson J, Ejlertsen B, et al. Histological grade and steroid receptor content of primary breast cancer - impact on prognosis and possible modes of action. Br J Cancer 1988;58:480-6.
5. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
6. Peto P, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977;35:1-39.
7. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986; 103:2787-96.
8. Tsuda H, Sakamaki C, Fukutomi T, Hirohashi S. Squamoid features and expression of involucrin in primary breast carcinoma associated with high histological grade, tumour cell necrosis and recurrence sites. Br J Cancer 1997;75:1519-24.
9. Tsuda H, Takarabe T, Hasegawa T, Murata T, Hirohashi S. Myoepithelial differentiation in high-grade invasive ductal carcinomas with large, central acellular zones. Hum Pathol 1999;30:1134-9.
10. Wetzels RH, Holland R, van Haelst UJ, Lane EB, Leigh IM, Ramaekers FC. Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast. Am J Pathol 1989;134:571-9.